Aim: Percutaneous Balloon Aortic Valvuloplasty (BAV) is actually recommended as a bridge to surgery or transcatheter aortic valve replacement in patients with severe Aortic Stenosis (AS) in particular clinical settings. In this study, we compared the two years mortality of 50 patients (mean age 86.8 ± 4.68 years) with symptomatic AS undergoing BAV which does not require rapid ventricular pacing, with the mortality tables provided from the Italian National Institute of Statistics (ISTAT) in a period between 2019 and 2021. Methods and Results: At a median of 25 months, 36% patients died. The median time between BAV and mortality was 11 months. The independent predictors of mortality were the NYHA class at admission and STS score. (p<0.01 for both). From the comparison between the percentages of our data and the prospective probability of survival calculated by ISTAT for the whole population of the Marche region and whole Italian territory the survival rates were higher in the population undergoing BAV than in the control population for the age groups of 85 to 89 and 90 to 94. Conclusion: Our data showed a higher long-term survival rate for the symptomatic patients with severe AS treated with BAV, in comparison with the prospective probability of survival calculated by ISTAT in the 2019, 2020 and 2021 for the age groups of 85 to 89 and 90 to 94 both in the Marche region and the whole Italian territory. Our encouraging results should be confirmed from larger future study.
Baawain S and Aladawi RD
Pérez-Sáncheza I, Ausina-Gómeza S, Izquierdo-Plazasa L and Cerrolaza-Uristoa N